sglt2 inhibitors and glp 1 receptor agonists SGLT-2 GLP-1 Agonists: First-Line Therapy for Diabetes With Established Cardiovascular Disease SGLT2 Inhibitors and GLP-1 Receptor
Description
[5] PR Newswire

You should also avoid taking any other weight-loss medications while on Saxenda

doi: 10.1345/aph.1H060 [DOI] [PubMed] [Google Scholar] 121

& Holst, J

HR, hazard ratio

18 In the same line, the SELECT trial showed that semaglutide administered once weekly reduced the risk of MACE by 20% compared to placebo in individuals with established cardiovascular disease but no DM
